CEREZYME Search (19 Results)

Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus ...

Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in ... A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal ...

http://www.bioportfolio.com/resources/trial/105530/Safety-and-Efficacy-of-Cerezyme-Infusio...
BioPortfolio.com - BioWeb REFLUDAN LEPIRUDIN RECOMBINANT veridia ...

... modified form of beta-glucocerebrosidase) - Genzyme - Treatment of type 1 Gaucher's disease - Apr 1991 Cerezyme® (imiglucerase; recombinant form of ...

http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe%3FDB%3Dsearch%26CMD%3Dexpand.auto%2...
Reportlinker Adds Genzyme Corporation: PharmaVitae Profile

17 Aug 2010 ... *See how the company's core products of Cerezyme, Fabrazyme and Myozyme/Lumizyme will continue to act as the primary sales growth drivers ...

http://www.bioportfolio.com/news/article/87788/Reportlinker-Adds-Genzyme-Corporation-Pharm...
BioPortfolio.com - BioWeb COZAAR LOSARTAN POTASSIUM Search

< td WIDTH="7%" VALIGN="middle" HEIGHT="18" style="font-family: MS Sans Serif; font-size: 8; border-bottom: 1px solid rgb(45,50108)"> 20-450 S-005 CEREZYME ...

http://www.bioportfolio.co.uk/COZAAR%2BLOSARTAN%2BPOTASSIUM-bioweb.htm
Genzyme-Corporation-PharmaVitae-Profile

*See how the company's core products of Cerezyme, Fabrazyme and Myozyme will continue to act as .... Table 35: Cerezyme: sales forecast ($m), 2007-13 116 ...

http://www.bioportfolio.com/store/product/1539/Genzyme-Corporation-PharmaVitae-Profile
Biosimilars A Growing Market

Abseamed, Actemra, Aldurazyme, Aranesp, Avastin, Avonex, Betaseron, Binocrit, Cerezyme, Cimzia, Enbrel, Epoetin, Epogen, ESPO, Feron, Glaritus, Granocyte, ...

http://www.bioportfolio.com/cgi-bin/acatalog/Biosimilars-A-Growing-Market.html
Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme

Genzyme: US Cerezyme Patients Return To Normal Dosing In Sept :: Published: 11: 39 EST Thursday the 26th of August 2010 | News by Moreover | 1 views total ...

http://www.bioportfolio.com/resources/trial/80206/Severe-Renal-Disease-Study-in-Fabry-Pati...
These highlights do not include all the information needed to use ...

Genzyme Ramping Up Cerezyme, Fabrazyme Shipments for Next Month :: Published: 00 :33 EST Saturday the 28th of August 2010 | News by Moreover | 1 views total ...

http://www.bioportfolio.com/resources/drug/5751/These-highlights-do-not-include-all-the-in...
Genzyme Reports Financial Results for the First Quarter of 2010

... was $1.07 billion, compared with $1.15 billion in the same period last year, reflecting limited shipments of Cerezyme® (imiglucerase for injection) a. ...

http://www.bioportfolio.com/news/article/8146/Genzyme-Reports-Financial-Results-for-the-Fi...
Genzyme will double shipments of rationed drugs

26 Aug 2010 ... Boston Globe | Patients taking Cerezyme, a treatment for Gaucher disease, will receive two doses in September compared to the one dose they ...

http://www.bioportfolio.com/news/article/109606/Genzyme-will-double-shipments-of-rationed-...
Genzyme eases drug shortage with increased shipments

... Genzyme Ramping Up Cerezyme, Fabrazyme Shipments for Next Month :: Published : 00:33 EST Saturday the 28th of August 2010 | News by Moreover | 2 views ...

http://www.bioportfolio.com/news/article/111215/Genzyme-Eases-Drug-Shortage-With-Increased...
A Phase III Trial to Assess the Safety and Efficacy of Plant Cell ...

... 19th of July 2010 | 0 views total; A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. ...

http://www.bioportfolio.com/resources/trial/104923/A-Phase-Iii-Trial-To-Assess-The-Safety-...
Genzyme disposes batches of 4 drugs because of quality control issues

11 Aug 2010 ... SmartBrief | Genzyme discarded batches of Gaucher disease drug Cerezyme, Fabry disease treatm... Original Article: Genzyme disposes batches ...

http://www.bioportfolio.com/news/article/78679/Genzyme-disposes-batches-of-4-drugs-because...
BioPortfolio - Indepth Browse

... Ceretec | Cerezyme | Cermet Cements | Cernevit | Cerubidine | Ceruloplasmin | Cerumen | Cerumenex | Cervical Cancer | Cervical Intraepithelial Neoplasia ...

http://www.bioportfolio.com/indepth/search/C.htm
Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year ...

4 Aug 2010... A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. ...

http://www.bioportfolio.com/resources/pmarticle/39298/Peripheral-neuropathy-in-adult-type-...
BioPortfolio Client Press Releases Site Map

... atugen extends agreement with Schering AG, includes RNA interference technology · Expanded Cerezyme Label Likely in Europe · Study Supports Arixtra ...

http://www.bioportfolio.com/news/site_map.htm
Primary bone angiosarcoma in a patient with Gaucher disease.

A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. :: Last Updated: 15:04 EST Monday the ...

http://www.bioportfolio.com/resources/pmarticle/21389/Primary-bone-angiosarcoma-in-a-patie...
Oral drug for Gaucher disease shows promise, Genzyme says

24 Aug 2010... Genzyme will resume normal shipment of Cerezyme next month :: Published: 19: 31 EST Saturday the 28th of August 2010 | News by Moreover ...

http://www.bioportfolio.com/news/article/104898/Oral-drug-for-Gaucher-disease-shows-promis...
Less is not always more: sugammadex and the risk of under-dosing.

... Genzyme: US Cerezyme Patients Return To Normal Dosing In :: Published: 10:44 EST Thursday the 26th of August 2010 | News by Moreover | 2 views total ...

http://www.bioportfolio.com/resources/pmarticle/52596/Less-is-not-always-more-sugammadex-a...